Search filters

List of works by Bernard Zinman

A 2-year Trial of Intermittent Insulin Therapy versus Metformin for the Preservation of Beta-cell Function after Initial Short-term Intensive Insulin Induction in early Type 2 Diabetes.

scientific article

A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes

scientific article

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

scientific article published in October 2002

A pilot school-based healthy eating and physical activity intervention improves diet, food knowledge, and self-efficacy for native Canadian children

scientific article published on 01 October 2005

A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree

scientific article published on February 2002

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

scientific article

ACE-I and ARBs in early diabetic nephropathy

scientific article published in December 2002

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians

scientific article

Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project

scientific article published on 13 March 2008

Adiponectin in a native Canadian population experiencing rapid epidemiological transition

scientific article published in December 2003

Administrative data algorithms can describe ambulatory physician utilization

scientific article

Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus

scientific article published on 21 April 2010

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

scientific article

An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal

scientific article

Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics

scientific article published on 21 March 2019

Antepartum determinants of rapid early-life weight gain in term infants born to women with and without gestational diabetes

scientific article published on 13 March 2014

Antihyperglycemic agents and cardiovascular outcomes: recent insights

scientific article published on 3 July 2017

Applications of ultrasensitive wavelength‐modulated differential photothermal radiometry to noninvasive glucose detection in blood serum ⬇️

scientific article published on August 29, 2012

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

scientific article

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?

scientific article published on 03 January 2020

Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study

scientific article

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

scientific article

Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample

scientific article

Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample

scientific article published on 13 March 2008

Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME

scientific article published on 06 February 2020

Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components

scientific article published on 27 October 2010

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial

scientific article published on 12 April 2017

Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population

scientific article published on 28 January 2010

Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.

scientific article published on 21 July 2009

Association of parity with risk of type 2 diabetes and related metabolic disorders

scientific article published in April 2002

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes

scientific article published on 18 January 2009

Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes ⬇️

scientific article

Associations of circulating 25(OH)D with cardiometabolic disorders underlying type 2 diabetes mellitus in an Aboriginal Canadian community

scientific article published on 20 April 2015

Associations of prenatal metabolic abnormalities with insulin and adiponectin concentrations in human milk

scientific article published on 29 February 2012

Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes

scientific article published on 28 March 2017

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

scientific article published on 12 February 2017

Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control

scientific article

Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy ⬇️

scientific article

Biomarkers of tubulointerstitial damage and function in type 1 diabetes

scientific article

Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy

scientific article published on 05 June 2018

Bladder cancer in the EMPA-REG OUTCOME trial.

scientific article published on 14 September 2017

Blood pressure-lowering effects of incretin-based diabetes therapies

scientific article published on October 2014

C-reactive protein and gestational diabetes: the central role of maternal obesity

scientific article published in August 2003

Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?

scientific article published on 10 November 2016

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

scientific article published on 01 March 2020

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

scientific article published on 11 July 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

scientific article published on 14 April 2019

Cardiometabolic Consequences of Gestational Dysglycemia ⬇️

scientific article published on March 21, 2013

Cardiometabolic implications of postpartum weight changes in the first year after delivery

scientific article published on 25 March 2014

Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial

scientific article published on 02 June 2020

Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

scientific article published in January 2018

Cardiovascular Outcome Trials in Diabetes: Will the EMPA-REG OUTCOME and LEADER Trials Influence Clinical Decisions in Type 2 Diabetes?

scientific article published on 01 October 2016

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum

scientific article

Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.

scientific article published on 13 November 2017

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

scientific article published on 04 May 2020

Cardiovascular disease and the use of insulin

scientific article published on 30 August 2013

Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada ⬇️

scientific article published on March 28, 2012

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial

scientific article published on 28 February 2013

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>

scientific article published on 01 November 2020

Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial

scientific article published on 12 November 2020

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

scientific article published on 5 December 2017

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)

scientific article published on 15 April 2019

Carotid Ultrasound in One, Two and Three Dimensions

article

Changes Over Time in Glycemic Control, Insulin Sensitivity, and β-Cell Function in Response to Low-Dose Metformin and Thiazolidinedione Combination Therapy in Patients With Impaired Glucose Tolerance ⬇️

scientific article published on July 1, 2011

Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia

scientific article published on 01 July 2018

Changes Over Time in Uric Acid in Relation to Changes in Insulin Sensitivity, Beta-Cell Function, and Glycemia

scientific article published on 01 March 2020

Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study

scientific article

Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy

scientific article

Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose co-transporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial

scientific article published on 09 November 2020

Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.

scientific article

Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths

scientific article

Circadian variation in the response to the glucose challenge test in pregnancy: implications for screening for gestational diabetes mellitus

scientific article

Circulating B-type natriuretic peptide in women with and without recent gestational diabetes: The impact of current glucose intolerance.

scientific article published on 7 November 2017

Circulating vitamin D metabolites and kidney disease in type 1 diabetes

scientific article

Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes

scientific article published on 25 March 2013

Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

scientific article published in March 2005

Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes

scientific article published on 09 July 2018

Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291-299

scientific article published on 01 July 2020

Comparison of National Diabetes Data Group and American Diabetes Association diagnostic criteria for gestational diabetes in their identification of postpartum risk of glucose intolerance

scientific article

Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors

scientific article published in August 2005

Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies

scientific article published on July 2010

Consistent Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of Diabetic Kidney Disease Categories - Insights from the EMPA-REG OUTCOME trial

scientific article published on 03 August 2020

Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c.

scientific article published in July 2005

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

scientific article published in November 2004

Cross-Sectional and Prospective Associations between Abdominal Adiposity and Proinsulin Concentration ⬇️

scientific article published on January 1, 2002

Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth

scientific article published on 30 March 2007

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

scientific article published on 15 September 2017

Data sharing is desirable, but benefits should not be exaggerated

scientific article

Day-to-day Fasting Self-monitored Blood Glucose Variability is Associated with Risk of Hypoglycaemia in Insulin-Treated Patients with Type 1 and Type 2 Diabetes: A Post Hoc Analysis of the SWITCH Trials

scientific article published on 26 November 2018

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).

scientific article published on 15 September 2017

Deficiencies in the quality of diabetes care: comparing specialist with generalist care misses the point

scientific article published on February 2007

Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum

scientific article published on 12 March 2015

Delivery by Caesarean section and infant cardiometabolic status at one year of age.

scientific article published in October 2014

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

scientific article

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.

scientific article

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial

scientific article published on 2 October 2013

Determinants of insulin resistance in infants at age 1 year: impact of gestational diabetes mellitus

scientific article

Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort

scientific article published on 24 November 2019

Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes

scientific article published on 15 October 2013

Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study ⬇️

scientific article

Diabetes Research and Care Through the Ages

scientific article published in October 2017

Diabetes care in the U.S. and Canada

scientific article published in July 2002

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions

scientific article published on December 2013

Diabetes mellitus and breast cancer: a retrospective population-based cohort study

scientific article published on 16 March 2006

Diabetes: Clinical inertia--a barrier to effective management of T2DM.

scientific article published on 17 September 2013

Diabetes: Progress in reducing vascular complications of diabetes

scientific article

Diabetes: Steno-2 - a small study with a big heart

scientific article published on 7 October 2016

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

scientific article

Dietary Patterns and Type 2 Diabetes Mellitus in a First Nations Community

scientific article published on 29 June 2016

Dietary intake and development of a quantitative food-frequency questionnaire for a lifestyle intervention to reduce the risk of chronic diseases in Canadian First Nations in north-western Ontario

scientific article published on 7 December 2007

Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions

scientific article published in February 2005

Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus

scientific article

Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits

article

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes

scientific article

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

scientific article published on 21 June 2020

Does hypoadiponectinemia explain the increased risk of diabetes and cardiovascular disease in South Asians?

scientific article published on 01 August 2006

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

scientific article published on 02 April 2019

EMPAGLIFLOZIN IS ASSOCIATED WITH A LOWER RISK OF POST-ACUTE HEART FAILURE RE-HOSPITALIZATION AND MORTALITY: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL

scholarly article

Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum

scientific article published on 17 September 2014

Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience

scientific article published on 23 May 2019

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME

scientific article published on 11 September 2020

Effect of Chronic Liraglutide Therapy and its Withdrawal on Time to Post-challenge Peak Glucose in Patients with Type 2 Diabetes

scientific article published on 28 November 2017

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

scientific article published on 09 August 2019

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial

scientific article published on 19 September 2019

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial

scientific article published on 01 January 2019

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

scientific article published on 01 May 2018

Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial

scientific article

Effect of Short-term Intensive Insulin Therapy on Post-challenge Hyperglucagonemia in Early Type 2 Diabetes

scientific article published on 16 June 2015

Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study

scientific article

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited

scientific article published on 25 January 2008

Effect of macronutrient intake during the second trimester on glucose metabolism later in pregnancy.

scientific article published on 28 September 2011

Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus ⬇️

scientific article published on May 22, 2012

Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study

scientific article published on 22 October 2008

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes

scientific article published on 29 October 2009

Effect of short‐term intensive insulin therapy on quality of life in type 2 diabetes ⬇️

scientific article published on September 16, 2010

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

scientific article published on 19 November 2020

Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial

scientific article published on 20 December 2020

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

scientific article published on 22 May 2020

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.

scientific article published in December 2018

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 14 September 2017

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial

scientific article published on 01 December 2020

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

scientific article published on 28 August 2017

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

scientific article

Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials

scientific article published on 03 August 2020

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

scientific article published on 17 March 2011

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

scientific article published in November 2002

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis

scientific article

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

scientific article published on 12 June 2017

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

scientific article published on 9 August 2016

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial

scientific article published on 01 November 2019

Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials

scientific article

Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial

scientific article

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

scientific article published on 16 March 2009

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial

scientific article published on 09 December 2019

Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials

scientific article

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

scientific article published on 17 September 2019

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study

scientific article published on 16 March 2017

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

scientific article published in October 2004

Emerging parameters of the insulin and glucose response on the oral glucose tolerance test: reproducibility and implications for glucose homeostasis in individuals with and without diabetes

scientific article

Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure

scientific article published on 05 June 2019

Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality

scientific article published on 01 March 2019

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

scientific article published on 01 March 2019

Empagliflozin Reduces Mortality and Hospitalization for Heart Failure in Patients with Type 2 Diabetes and Peripheral Artery Disease: A Sub-Analysis of the EMPA-REG OUTCOME Trial

scholarly article

Empagliflozin Reduces Mortality in Patients with Type 2 Diabetes and a History of Left Ventricular Hypertrophy: A Sub-Analysis of the EMPA-REG OUTCOME Trial

scholarly article

Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial

scientific article published on 13 November 2017

Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.

scientific article

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

scientific article

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

scientific article published on 13 September 2017

Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial

scientific article published on 12 October 2018

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

scientific article published on 14 June 2016

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials

scientific article published on 04 October 2018

Empagliflozin for Patients with Presumed Resistant Hypertension: a Post Hoc Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 05 May 2020

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

scientific article

Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial

scientific article published on 31 July 2018

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

scientific article published on 19 May 2018

Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial

scientific article published on 29 March 2020

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article published on 01 March 2016

Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy ⬇️

scientific article published on May 29, 2013

Erratum to “Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions” [Atherosclerosis 178(2) (2005) 319–325]

scholarly article published in Atherosclerosis

Erythropoietin and glucose homeostasis in women at varying degrees of future diabetic risk.

scientific article published on 16 September 2014

Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women

scientific article

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

scientific article published on 11 November 2019

Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes

scientific article published on 29 March 2016

Examining the relationship between maternal body size, gestational glucose tolerance status, mode of delivery and ethnicity on human milk microbiota at three months post-partum

scientific article published on 20 July 2020

Fasting Capillary Glucose as a Screening Test for Ruling Out Gestational Diabetes Mellitus ⬇️

scientific article published on June 1, 2013

Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy.

scientific article published on 18 February 2015

Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes

scientific article published in June 2003

Genes, environment and Oji-Cree type 2 diabetes ⬇️

scientific article published on May 1, 2003

Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis

article

Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study

scientific article

Gestational diabetes and postpartum physical activity: evidence of lifestyle change 1 year after delivery

scientific article

Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)

scientific article published on 30 October 2019

Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia

scientific article

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

scientific article published on 11 September 2014

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

scientific article published on 27 June 2019

Glucose Lowering Strategies for Cardiac Benefits: Pathophysiological Mechanisms

scientific article published on 01 May 2018

Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes

scientific article published on 15 July 2008

Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women

scientific article

Glycemic variability in patients with early type 2 diabetes: the impact of improvement in β-cell function

scientific article published on 18 February 2014

HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community

scientific article

HNF1AG319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study ⬇️

scientific article published on January 5, 2011

HbA1c, Insulin Resistance, and β-Cell Function in Relation to Cognitive Function in Type 2 Diabetes: The CAROLINA Cognition Substudy.

scientific article

Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME

scientific article published on 25 June 2020

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

scientific article

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

scientific article published on 15 November 2019

Hepatic Insulin Resistance Is an Early Determinant of Declining β-Cell Function in the First Year Postpartum After Glucose Intolerance in Pregnancy ⬇️

scientific article published on September 16, 2011

Hepatic fat and glucose tolerance in women with recent gestational diabetes

article published in 2018

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 4 December 2017

How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial

scholarly article

Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test

scientific article

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience

INTERMITTENT INTENSIVE INSULIN THERAPY FOR TYPE 2 DIABETES: EFFECTS ON HYPOGLYCEMIA, WEIGHT GAIN, AND QUALITY OF LIFE OVER 2 YEARS

scientific article published on 06 June 2019

Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome

scientific article published in November 2003

Impact of Changes Over Time in Adipokines and Inflammatory Proteins on Changes in Insulin Sensitivity, β-Cell Function, and Glycemia in Women With Previous Gestational Dysglycemia.

scientific article published on 14 June 2017

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

scientific article published on 14 November 2017

Impact of Maternal Physical Activity and Infant Feeding Practices on Infant Weight Gain and Adiposity ⬇️

scientific article published on September 26, 2012

Impact of daily incremental change in environmental temperature on beta cell function and the risk of gestational diabetes in pregnant women

scientific article published on 15 August 2018

Impact of maternal metabolic abnormalities in pregnancy on human milk and subsequent infant metabolic development: methodology and design.

scientific article

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials

scientific article published on 09 July 2020

Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon Secretion

scientific article published on 3 May 2017

Impaired fasting glucose and impaired glucose tolerance: implications for care

scientific article

Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test

scientific article published in January 2006

Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control

article

Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes

scientific article published on 15 March 2019

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial

scientific article published in October 2005

Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time? ⬇️

scientific article published on January 1, 2011

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

scientific article published on 11 December 2020

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

scientific article

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

scientific article published on March 2011

Insulins: Past, Present, and Future ⬇️

scientific article published on April 12, 2012

Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes ⬇️

scientific article published on November 12, 2011

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

scientific article

Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction

scientific article published on 20 March 2008

LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes

scientific article published on 05 June 2006

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial

scientific article

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.

scientific article

Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population

scientific article published in March 2006

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

scientific article published on 01 January 2019

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use

scientific article published on 01 October 2018

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

scientific article

Liraglutide and Glycaemic Outcomes in the LEADER Trial

Liraglutide and Renal Outcomes in Type 2 Diabetes

scientific article published on August 2017

Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial

scientific article

Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes

scientific article published on 20 November 2014

Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease

scientific article published on 01 October 2018

Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial

scientific article published on 07 July 2019

Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus

scientific article published on 12 June 2013

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort

scientific article

Longitudinal Associations of Phospholipid and Cholesteryl Ester Fatty Acids With Disorders Underlying Diabetes

scientific article published on 4 May 2016

Longitudinal changes in estimated and measured GFR in type 1 diabetes

scientific article published on 05 December 2013

Low serum levels of high-molecular weight adiponectin in Indo-Asian women during pregnancy: evidence of ethnic variation in adiponectin isoform distribution

scientific article published in June 2006

Low-Dose Combination Therapy With Rosiglitazone And Metformin to Prevent Type 2 Diabetes Mellitus (CANOE Trial): A Double-Blind Randomized Controlled Study

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

scientific article published on 3 June 2010

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

scientific article published on 01 April 2019

Major gaps in diabetes clinical care among Canada's First Nations: results of the CIRCLE study

scientific article published on 3 March 2011

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

scientific article published on August 2006

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for th

scientific article published in January 2008

Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes

scientific article published on 26 April 2016

Maternal insulin sensitivity during pregnancy predicts infant weight gain and adiposity at 1 year of age.

scientific article

Maternal obesity and familial history of diabetes have opposing effects on infant birth weight in women with mild glucose intolerance in pregnancy

scientific article published in January 2008

Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution

scientific article published on 27 April 2007

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article

Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting

scientific article published in April 2004

Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community

scientific article published on March 2009

Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations

scientific article published in January 2006

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

scientific article published on 26 November 2020

Metabolically healthy overweight and obesity

Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial

scientific article

Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes

scientific article

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

scientific article

Neighborhood walkability and risk of gestational diabetes

scientific article published on 01 February 2020

Newer insulin analogs: advances in basal insulin replacement ⬇️

scientific article published on March 1, 2013

Noninvasive glucose detection in human skin using wavelength modulated differential laser photothermal radiometry ⬇️

scientific article published on October 29, 2012

Nontraditional cardiovascular risk factors in pediatric metabolic syndrome

scientific article published on February 2006

Novel Diabetes Drugs and the Cardiovascular Specialist

scientific article

Nutrient intake and food use in an Ojibwa-Cree community in Northern Ontario assessed by 24h dietary recall

scholarly article

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes

scientific article published in August 2006

Oscar B. Crofford: Clinician, scientist, educator, advocate for people with diabetes, and godfather of diabetes control and complications trial

scientific article published in December 2014

Oxidative stress and endothelial dysfunction are associated with reduced cognition in type 2 diabetes

scientific article published on 09 May 2019

Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI)

scientific article

Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort

scientific article published on 9 February 2015

Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes

scientific article published on 01 May 2007

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe

scientific article published in December 2004

Postpartum Metabolic Function in Women Delivering a Macrosomic Infant in the Absence of Gestational Diabetes Mellitus ⬇️

scientific article published on October 4, 2011

Postpartum microalbuminuria after gestational diabetes: the impact of current glucose tolerance status

scientific article published on 05 January 2015

Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity

scientific article

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes

scientific article published on 16 November 2018

Predictors and clinical implications of a false negative glucose challenge test in pregnancy

scientific article published in October 2013

Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes

scientific article published on August 2016

Prevention or delay of type 2 diabetes

scientific article published on January 2004

Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity

scientific article published on 13 December 2016

Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus

scientific article

Prospective association of 25(OH)D with metabolic syndrome

scientific article published in April 2013

Prospective associations of vitamin D status with β-cell function, insulin sensitivity, and glycemia: the impact of parathyroid hormone status

scientific article published on 29 May 2014

Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study

scientific article

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

scientific article published on 15 January 2018

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.

scientific article published on 21 December 2015

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

scientific article

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high

scientific article published on 14 March 2018

Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes

scientific article published in March 2004

Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial

scientific article published on 01 January 2020

Relationship between short stature and postchallenge glycemia in pregnancy

scientific article published on December 2010

Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus

scientific article

Relationship of the metabolic syndrome to carotid ultrasound traits

scientific article

Renal and retinal effects of enalapril and losartan in type 1 diabetes

scientific article

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy

scientific article

Renal outcomes in patients with type 1 diabetes and macroalbuminuria

scientific article

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

scientific article published on 01 May 2020

Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"

scientific article published on 01 August 2018

Response by Zinman et al to Letter Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk".

scientific article

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.

scientific article

Response to Comment on Retnakaran et al. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 2014;37:3270-3278

scientific article published on 01 February 2015

Response to Comment on: Goldberg et al. Circadian Variation in the Response to the Glucose Challenge Test in Pregnancy: Implications for Screening for Gestational Diabetes Mellitus. Diabetes Care 2012;35:1578–1584 ⬇️

scientific article published on March 1, 2013

Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

scientific article published in October 2014

Response to comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.

scientific article published in September 2014

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial

scientific article published on 31 January 2019

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes

scientific article published on 09 October 2018

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

scientific article published on 01 November 2020

Risk of development of diabetes mellitus after diagnosis of gestational diabetes

scientific article published on July 2008

Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum

scientific article published on October 2010

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

scientific article

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

scientific article

SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials

scientific article

SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA.

scientific article published on 30 April 2019

Screening Glucose Challenge Test in Pregnancy Can Identify Women With an Adverse Postpartum Cardiovascular Risk Factor Profile: Implications for Cardiovascular Risk Reduction

scientific article published on 28 October 2019

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

scientific article published on 01 March 2019

Serum Ferritin and Glucose Homeostasis in Women With Recent Gestational Diabetes

scientific article published on 21 June 2019

Serum apoA1 (Apolipoprotein A-1), Insulin Resistance, and the Risk of Gestational Diabetes Mellitus in Human Pregnancy-Brief Report

scientific article published on 15 August 2019

Sex Disparities in Cardiovascular Outcome Trials of Populations With Diabetes: A Systematic Review and Meta-analysis

scientific article published on 01 May 2020

Sex of the baby and risk of gestational diabetes mellitus in the mother: a systematic review and meta-analysis

scientific article published on 08 August 2015

Short leg length, a marker of early childhood deprivation, is associated with metabolic disorders underlying type 2 diabetes: the PROMISE cohort study

scientific article published on 02 October 2013

Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 06 September 2020

Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)

scientific article published on 14 April 2019

Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis

scientific article published on 04 February 2013

Similarities and differences in cardiometabolic risk factors among remote Aboriginal Australian and Canadian cohorts

scientific article published on 9 January 2013

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes

scientific article published on 26 September 2018

Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol

scientific article published on 30 June 2019

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus: the road ahead

scientific article published on 05 May 2016

Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial

scientific article published on 4 March 2014

Stages of change for healthy eating in diabetes: relation to demographic, eating-related, health care utilization, and psychosocial factors

scientific article published in May 2003

Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study

scientific article published on 21 December 2011

THE ASSOCIATION BETWEEN URIC ACID LEVELS AND CARDIORENAL OUTCOMES AND DEATH IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME

scholarly article

THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME

scholarly article

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

scientific article published on 13 December 2017

The Distribution of Fatty Acid Biomarkers of Dairy Intake across Serum Lipid Fractions: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

scientific article published on 19 August 2019

The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial

scientific article published on 31 July 2015

The Impact of Empagliflozin on Obstructive Sleep Apnea, Cardiovascular, and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 01 October 2020

The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function

scientific article published on 01 March 2020

The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy

scientific article published on 19 February 2016

The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes

scientific article

The authors reply

article published in 2020

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study: 30th anniversary presentations

scientific article

The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial

scientific article published in April 2007

The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes In

scientific article published on 04 December 2012

The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

scientific article published on December 2006

The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk

scientific article published on 14 July 2010

The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population

scientific article published in February 2002

The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial

scientific article published on 11 March 2020

The impact of family history of diabetes on risk factors for gestational diabetes

scientific article published on 03 July 2007

The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes

scientific article

The persistence of maternal vitamin D deficiency and insufficiency during pregnancy and lactation irrespective of season and supplementation

scientific article

The prevention or delay of type 2 diabetes

article

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study

scientific article

Thiazolidinediones and clinical outcomes in type 2 diabetes

scientific article published on 6 June 2009

Traditional foods and 25(OH)D concentrations in a subarctic First Nations community

scientific article published on January 2016

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

scientific article

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

scientific article published on 11 August 2014

Type 1 diabetes, hyperglycaemia, and the heart

scientific article published on May 2008

Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective.

scientific article published on 9 May 2007

Type 2 diabetes mellitus: magnitude of the problem and failure to achieve glycemic control

scientific article published on December 2006

Vitamin D and parathyroid hormone status in pregnancy: effect on insulin sensitivity, β-cell function, and gestational diabetes mellitus

scientific article published in December 2014

Vitamin D status and cardiometabolic assessment in infancy ⬇️

scientific article published on June 4, 2013

White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals--the PROMISE cohort

scientific article published on 16 January 2014

[Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]

scientific article published on 01 May 2012

Paulina is supported by:

About Paulina

Help